iTeos Therapeutics-ITeos Therapeutics, Inc. (ITOS) Reports Q2 Loss, Tops Revenue Estimates

ITeos Therapeutics, Inc. (ITOS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of$ 1.04. This compares to loss of $0.96 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 82.69%. A quarter ago, it was expected that this company would post a loss of$ 1.02 per share when it actually produced a loss of $1.07, delivering a surprise of -4.90%. Over the last four quarters, the company h ...